EUCTR2006-001094-15-GB进行中（未招募）1 期
Dose-banding of carboplatin: Effect on area under the plasma concentration - time curve (AUC) compared with individualised dosing - Carboplatin blood levels with dose-banded” and individualised systems
Oxford Radcliffe Hospitals NHS Trust (Cancer Research UK Medical Oncology Unit, Churchill Hospital)0 个研究点目标入组 10 人开始时间: 2006年4月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Patients aged over 18.
- •- Eligible to receive carboplatin as single agent or in combination therapy, according to institutional guidelines.
- •- At least two planned carboplatin cycles.
- •- Ability to give informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Patients with ascites, oedema, or other expanded body space.
- •- Patients receiving intravenous (IV) hydration therapy.
- •- Pregnancy or breast feeding.
- •- Patients who do not understand the Patient Information sheet in English. (Considering the size and purpose of this study, it would not be economically feasible to provide separate information material in other languages for anyone who does not fully understand the Patient Information).
研究者
相似试验
招募中
3 期
ACNS0332: Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients - A Groupwide Phase III Studymedulloblastoma10029211malignant brain tumorpnetNL-OMON41634Stichting Kinderoncologie Nederland21
进行中（未招募）
不适用
Study to determine the precision and safety of the anticancer drug carboplatin after dosing according to a new dosing algoritmEUCTR2014-000234-33-NLrijnstate hospital, the netherlands
已完成
4 期
PHARMACOKINETICS OF CARBOPLATIN AFTER ADJUSTED DOSING FOR HIGH BMI, LOW SERUM CREATININE, AND MAXIMAL RENAL FUNCTIOlung cancerovarian cancer10027656NL-OMON44328ziekenhuisapotheek24
招募中
1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancerocally Advanced Non-Small Cell Lung CancerJPRN-UMIN000016730Foundation for Biomedical Research and Innovation43
进行中（未招募）
不适用
A randomised Phase II study of carboplatin with or without the addition of the ETAR inhibitor ZD4054 as treatment for patients with metastatic breast cancer. - PLANETMetastatic Breast CancerEUCTR2010-018837-23-GBCardiff University